Reuters logo
BRIEF-EU medicines agency backs new drugs from Novo Nordisk, J&J, Gilead
July 25, 2014 / 11:16 AM / 3 years ago

BRIEF-EU medicines agency backs new drugs from Novo Nordisk, J&J, Gilead

July 25 (Reuters) - The European Medicines Agency: * EU medicines agency says recommends Novo Nordisk diabetes

treatment degludec/liraglutide * EU medicines agency says recommends Johnson & Johnson Pharmacyclics

leukaemia drug ibrutinib * EU medicines agency says recommends Gilead Sciences leukaemia drug

idelalisib

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below